Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.7250
-0.0367 (-4.82%)
Feb 6, 2026, 4:00 PM EST - Market closed
Pasithea Therapeutics Market Cap
Pasithea Therapeutics has a market cap or net worth of $16.74 million as of February 9, 2026. Its market cap has increased by 430.89% in one year.
Market Cap
16.74M
Enterprise Value
12.62M
1-Year Change
430.89%
Ranking
Category
Stock Price
$0.73
Market Cap Chart
Since the IPO on September 15, 2021, Pasithea Therapeutics's market cap has decreased from $65.29M to $16.74M, a decrease of -74.36%. That is a compound annual growth rate of -26.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 16.74M | -43.80% |
| Dec 31, 2025 | 29.79M | 646.69% |
| Dec 31, 2024 | 3.99M | -48.26% |
| Dec 29, 2023 | 7.71M | -58.92% |
| Dec 30, 2022 | 18.77M | -51.55% |
| Dec 31, 2021 | 38.74M | -40.66% |
| Sep 15, 2021 | 65.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NanoViricides | 18.98M |
| VYNE Therapeutics | 18.63M |
| Lexaria Bioscience | 18.04M |
| Klotho Neurosciences | 17.66M |
| Genenta Science | 17.15M |
| FibroBiologics | 16.74M |
| Quantum BioPharma | 16.02M |
| Iterum Therapeutics | 15.96M |